This data indicated that MIP-1β could also recruit MDSCs and CD68+CD163+M2-like macrophages of NSCLC patients during radiotherapy, thereby playing a vital role in evaluating the inflammation environment of radiation therapy. This evidence concerns the gene CD163 and non-small cell lung carcinoma.